Lindgren H, Eneslatt K, Golovliov I, Gelhaus C, Sjostedt A
Front Immunol. 2023; 14:1238391.
PMID: 37781364
PMC: 10540638.
DOI: 10.3389/fimmu.2023.1238391.
Liu Q, Leclerc S, Pan Y, Liu Z, Stark F, Conlan J
Microorganisms. 2022; 10(1).
PMID: 35056485
PMC: 8778127.
DOI: 10.3390/microorganisms10010036.
Nicol M, Williamson D, Place D, Kirimanjeswara G
Microorganisms. 2021; 9(5).
PMID: 33946283
PMC: 8145380.
DOI: 10.3390/microorganisms9050973.
Stefanetti G, Okan N, Fink A, Gardner E, Kasper D
Proc Natl Acad Sci U S A. 2019; 116(14):7062-7070.
PMID: 30872471
PMC: 6452683.
DOI: 10.1073/pnas.1900144116.
Eneslatt K, Golovliov I, Ryden P, Sjostedt A
Front Cell Infect Microbiol. 2018; 8:27.
PMID: 29468144
PMC: 5808333.
DOI: 10.3389/fcimb.2018.00027.
Inflammasome-Independent NLRP3 Restriction of a Protective Early Neutrophil Response to Pulmonary Tularemia.
Periasamy S, Le H, Duffy E, Chin H, Harton J
PLoS Pathog. 2016; 12(12):e1006059.
PMID: 27926940
PMC: 5142794.
DOI: 10.1371/journal.ppat.1006059.
Gallium Potentiates the Antibacterial Effect of Gentamicin against Francisella tularensis.
Lindgren H, Sjostedt A
Antimicrob Agents Chemother. 2015; 60(1):288-95.
PMID: 26503658
PMC: 4704213.
DOI: 10.1128/AAC.01240-15.
In vivo mechanisms involved in enhanced protection utilizing an Fc receptor-targeted mucosal vaccine platform in a bacterial vaccine and challenge model.
Bitsaktsis C, Babadjanova Z, Gosselin E
Infect Immun. 2014; 83(1):77-89.
PMID: 25312957
PMC: 4288904.
DOI: 10.1128/IAI.02289-14.
Protective immunity against lethal F. tularensis holarctica LVS provided by vaccination with selected novel CD8+ T cell epitopes.
Rotem S, Cohen O, Bar-Haim E, Bar-On L, Ehrlich S, Shafferman A
PLoS One. 2014; 9(1):e85215.
PMID: 24400128
PMC: 3882263.
DOI: 10.1371/journal.pone.0085215.
MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection.
Meierovics A, Chua Yankelevich W, Cowley S
Proc Natl Acad Sci U S A. 2013; 110(33):E3119-28.
PMID: 23898209
PMC: 3746930.
DOI: 10.1073/pnas.1302799110.
IKKβ in myeloid cells controls the host response to lethal and sublethal Francisella tularensis LVS infection.
Samaniego S, Marcu K
PLoS One. 2013; 8(1):e54124.
PMID: 23349802
PMC: 3551972.
DOI: 10.1371/journal.pone.0054124.
Clusters versus affinity-based approaches in F. tularensis whole genome search of CTL epitopes.
Zvi A, Rotem S, Cohen O, Shafferman A
PLoS One. 2012; 7(5):e36440.
PMID: 22563500
PMC: 3341354.
DOI: 10.1371/journal.pone.0036440.
Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia.
Crane D, Scott D, Bosio C
PLoS One. 2012; 7(3):e33349.
PMID: 22428026
PMC: 3299770.
DOI: 10.1371/journal.pone.0033349.
Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine.
Kim T, Pinkham J, Heninger S, Chalabaev S, Kasper D
J Infect Dis. 2011; 205(7):1056-65.
PMID: 21969334
PMC: 3295600.
DOI: 10.1093/infdis/jir620.
Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets.
Valentino M, Maben Z, Hensley L, Woolard M, Kawula T, Frelinger J
Immunology. 2011; 132(3):348-60.
PMID: 21214540
PMC: 3044901.
DOI: 10.1111/j.1365-2567.2010.03387.x.
Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.
Anderson R, Crane D, Bosio C
Vaccine. 2010; 28(40):6562-72.
PMID: 20688042
PMC: 2939155.
DOI: 10.1016/j.vaccine.2010.07.072.
The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis.
Markel G, Bar-Haim E, Zahavy E, Cohen H, Cohen O, Shafferman A
PLoS One. 2010; 5(6):e11176.
PMID: 20585449
PMC: 2887844.
DOI: 10.1371/journal.pone.0011176.
Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS).
Twine S, Petit M, Fulton K, House R, Conlan J
PLoS One. 2010; 5(4):e10000.
PMID: 20368994
PMC: 2848853.
DOI: 10.1371/journal.pone.0010000.
Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4.
Gregory S, Chen W, Mott S, Palardy J, Parejo N, Heninger S
Vaccine. 2010; 28(16):2908-15.
PMID: 20170768
PMC: 2847053.
DOI: 10.1016/j.vaccine.2010.01.067.
Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development.
Pechous R, McCarthy T, Zahrt T
Microbiol Mol Biol Rev. 2009; 73(4):684-711.
PMID: 19946137
PMC: 2786580.
DOI: 10.1128/MMBR.00028-09.